<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">42426</article-id><article-id pub-id-type="doi">10.7554/eLife.42426</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-123159"><name><surname>Ma</surname><given-names>Xiancai</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123160"><name><surname>Yang</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123161"><name><surname>Luo</surname><given-names>Yuewen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123162"><name><surname>Wu</surname><given-names>Liyang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-128497"><name><surname>Jiang</surname><given-names>Yawen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-128498"><name><surname>Song</surname><given-names>Zheng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123163"><name><surname>Pan</surname><given-names>Ting</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123164"><name><surname>Liu</surname><given-names>Bingfeng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123165"><name><surname>Liu</surname><given-names>Guangyan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123166"><name><surname>Liu</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123167"><name><surname>Yu</surname><given-names>Fei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123168"><name><surname>He</surname><given-names>Zhangping</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123169"><name><surname>Zhang</surname><given-names>Wanying</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123170"><name><surname>Yang</surname><given-names>Jinyu</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123171"><name><surname>Liang</surname><given-names>Liting</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123172"><name><surname>Guan</surname><given-names>Yuanjun</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123173"><name><surname>Zhang</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123174"><name><surname>Li</surname><given-names>Linghua</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123175"><name><surname>Cai</surname><given-names>Weiping</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123176"><name><surname>Tang</surname><given-names>Xiaoping</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123177"><name><surname>Gao</surname><given-names>Song</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7427-6681</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123178"><name><surname>Deng</surname><given-names>Kai</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-122372"><name><surname>Zhang</surname><given-names>Hui</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3620-610X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Institute of Human Virology, Zhongshan School of Medicine</institution>, <institution>Sun Yat-sen University</institution>, <addr-line><named-content content-type="city">Guangzhou</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">College of Basic Medical Sciences</institution>, <institution>Shenyang Medical College</institution>, <addr-line><named-content content-type="city">Shenyang</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine</institution>, <institution>Sun Yat-Sen University Cancer Center</institution>, <addr-line><named-content content-type="city">Guangzhou</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution content-type="dept">Core Laboratory Platform for Medical Science, Zhongshan School of Medicine</institution>, <institution>Sun Yat-sen University</institution>, <addr-line><named-content content-type="city">Guangzhou</named-content></addr-line>, <country>China</country></aff><aff id="aff5"><institution content-type="dept">Department of Infectious Diseases</institution>, <institution>Guangzhou 8th People's Hospital</institution>, <addr-line><named-content content-type="city">Guangzhou</named-content></addr-line>, <country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-55312"><name><surname>Luban</surname><given-names>Jeremy</given-names></name><role>Reviewing editor</role><aff><institution>University of Massachusetts Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>zhangh92@mail.sysu.edu.cn</email> (HZ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>01</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e42426</elocation-id><history><date date-type="received"><day>28</day><month>09</month><year>2018</year></date><date date-type="accepted"><day>16</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Ma et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Ma et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-42426-v1.pdf"/><abstract><p>Comprehensively elucidating the molecular mechanisms of human immunodeficiency virus type 1 (HIV-1) latency is a priority to achieve a functional cure. As current 'shock' agents failed to efficiently reactivate the latent reservoir, it is important to discover new targets for developing more efficient latency-reversing agents (LRAs). Here we found that TRIM28 potently suppresses HIV-1 expression by utilizing both SUMO E3 ligase activity and epigenetic adaptor function. Through global site-specific SUMO-MS study and serial SUMOylation assays, we identified that P-TEFb catalytic subunit CDK9 is significantly SUMOylated by TRIM28 with SUMO4. The Lys44, Lys56 and Lys68 residues on CDK9 are SUMOylated by TRIM28, which inhibits CDK9 kinase activity or prevents P-TEFb assembly by directly blocking the interaction between CDK9 and Cyclin T1, subsequently inhibits viral transcription and contributes to HIV-1 latency. The manipulation of TRIM28 and its consequent SUMOylation pathway could be the target for developing LRAs.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>National Special Research Program of China for Important Infectious Diseases</institution></institution-wrap></funding-source><award-id>2017ZX10202102</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Important Key Program of Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81730060</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>International Collaboration Program of Natural Science Foundation of China and US NIH</institution></institution-wrap></funding-source><award-id>81561128007</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Joint-innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou</institution></institution-wrap></funding-source><award-id>201803040002</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>National Special Research Program of China for Important Infectious Diseases</institution></institution-wrap></funding-source><award-id>2018ZX10302103</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Chronically HIV-1-infected participants sampled by this study were recruited from Department of Infectious Diseases in Guangzhou 8th People's Hospital, Guangzhou. The Ethics Review Board of Sun Yat-Sen University and the Ethics Review Board of Guangzhou 8th People's Hospital approved this study. All the participants were given written informed consent with approval of the Ethics Committees. The enrollment of HIV-1-infected individuals was based on the criteria of prolonged suppression of plasma HIV-1 viremia on cART, which is undetectable plasma HIV-1 RNA levels (less than 50 copies/ml) for a minimum of six months, and having high CD4+ T cell count (at least 350 cells/mm3). Blood samples from healthy individuals were obtained from Guangzhou Blood Center. We did not have any interaction with the healthy individuals or protected information, and therefore no informed consent was required. The statement was also included in the Materials and Methods section.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-42426-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>